Cover Image
市場調查報告書

腎絲球腎炎:全球臨床實驗趨勢

Glomerulonephritis Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 325940
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
腎絲球腎炎:全球臨床實驗趨勢 Glomerulonephritis Global Clinical Trials Review, H2, 2015
出版日期: 2015年09月10日 內容資訊: 英文 78 Pages
簡介

本報告提供腎絲球腎炎相關之臨床研究最新趨勢調查,提供您地區·進展·PHASE·募集情況別的實驗量,代表性贊助商,開發中的治療藥資訊,並彙整全球各國的主要企業·機關的進展,有潛力的藥劑比較等資訊。

簡介

  • 腎絲球腎炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:泌尿系統生殖器系·性荷爾蒙治療藥臨床實驗上腎絲球腎炎的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:泌尿系統生殖器系·性荷爾蒙治療藥臨床實驗上腎絲球腎炎的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

腎絲球腎炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Isis Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
    • Celldex Therapeutics, Inc.
    • Anthera Pharmaceuticals, Inc.
    • Pharmalink AB
    • Osprey Pharmaceuticals U.S.A., Inc.
    • La Jolla Pharmaceutical Company
    • 第一三共
    • Bristol-Myers Squibb Company
    • Amgen Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Chinese University of Hong Kong
    • Radboud University
    • National Taiwan University Hospital
    • Centre Hospitalier Universitaire de Saint Etienne
    • Columbia University
    • Hospital Authority
    • The Rogosin Institute
    • Mayo Clinic
    • Ministry of Health, Labour and Welfare, Japan

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2856CTIDB

GlobalData's clinical trial report, "Glomerulonephritis Global Clinical Trials Review, H2, 2015" provides an overview of Glomerulonephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Glomerulonephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Glomerulonephritis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Glomerulonephritis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Glomerulonephritis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Regulus Therapeutics Inc.
      • Clinical Trial Overview of Regulus Therapeutics Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Celldex Therapeutics, Inc.
      • Clinical Trial Overview of Celldex Therapeutics, Inc.
      • Anthera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Anthera Pharmaceuticals, Inc.
      • Alexion Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alexion Pharmaceuticals, Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Alfa Wassermann S.p.A
      • Clinical Trial Overview of Alfa Wassermann S.p.A
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Columbia University
      • Clinical Trial Overview of Columbia University
      • Hospital Authority
      • Clinical Trial Overview of Hospital Authority
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Ministry of Health, Labour and Welfare, Japan
      • Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • University of Washington
      • Clinical Trial Overview of University of Washington
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Glomerulonephritis Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Glomerulonephritis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Glomerulonephritis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Glomerulonephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Regulus Therapeutics Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals, Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015*

List of Figures

  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Glomerulonephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top